Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4145)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 14, 2022 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li SQ, Yang Y, Ye LS. Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy. World J Gastroenterol 2022; 28(42): 6034-6044 [PMID: 36405383 DOI: 10.3748/wjg.v28.i42.6034] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i42/6034.htm |
| Number | Citing Articles |
| 1 |
Sujuan Peng, Hongxiang Huang, Xie Zhu, Jinhong Chen, Xinjing Ding, Fen Wang, Li Chen, Zhihui Lu. Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report. Experimental and Therapeutic Medicine 2024; 27(5) doi: 10.3892/etm.2024.12466
|
| 2 |
Chunhong Tian, Yifan Yu, Yuqing Wang, Lunwei Yang, Ying Tang, Chengyang Yu, Gaofei Feng, Dayong Zheng, Xiongwen Wang. Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352873
|
| 3 |
Qin Shi, Peng Huang, Zihan Zhang, Wen Zhang, Lingxiao Liu, Zhiping Yan. Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma 2023; : 1861 doi: 10.2147/JHC.S426308
|
| 4 |
Ping Yu, Yaru Wang, Dahai Yuan, Yunqin Sun, Shuang Qin, Tianye Li. Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1276694
|
| 5 |
Li Gu, Xin Jin, Huaiyuan Liang, Chong Yang, Yu Zhang. Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex. Pharmacological Research 2023; 192: 106789 doi: 10.1016/j.phrs.2023.106789
|
| 6 |
Siqi Li, Kun Li, Kang Wang, Haoyuan Yu, Xiangyang Wang, Mengchen Shi, Zhixing Liang, Zhou Yang, Yongwei Hu, Yang Li, Wei Liu, Hua Li, Shuqun Cheng, Linsen Ye, Yang Yang. Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-43462-1
|